Assignee
ARK DIAGNOSTICS INC
US·21 granted patents·8 pending applications·64 citations·filing 2004–2024
Top patents by PatentIndex Score
29 records- 0198US10919982B2Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2020·Granted Feb 16, 2021·6 cites·22 claims
- 0297US11525835B2Compounds and methods for use in detecting gabapentinARK DIAGNOSTICS INC·Filed 2022·Granted Dec 13, 2022·4 cites·30 claims
- 0397US11459403B2Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2021·Granted Oct 4, 2022·3 cites·20 claims
- 0497US11402395B2Compounds and methods for use in detecting gabapentinARK DIAGNOSTICS INC·Filed 2021·Granted Aug 2, 2022·4 cites·17 claims
- 0597US11136412B2Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2021·Granted Oct 5, 2021·3 cites·28 claims
- 0696US10745492B1Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2019·Granted Aug 18, 2020·6 cites·5 claims
- 0796US10717787B1Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2019·Granted Jul 21, 2020·7 cites·20 claims
- 0895US10203345B2Compounds and methods for use in detecting gabapentinARK DIAGNOSTICS INC·Filed 2016·Granted Feb 12, 2019·8 cites·29 claims
- 0992US11231424B2Levetiracetam immunoassaysARK DIAGNOSTICS INC·Filed 2019·Granted Jan 25, 2022·4 cites·11 claims
- 1091US9522880B2Compounds and methods for use in detecting gabapentinARK DIAGNOSTICS INC·Filed 2014·Granted Dec 20, 2016·7 cites·11 claims
- 1188US9958464B2Pregabalin immunoassaysARK DIAGNOSTICS INC·Filed 2016·Granted May 1, 2018·3 cites·21 claims
- 1288US2024192236A1Compounds and Methods for Use in Detecting GabapentinARK DIAGNOSTICS INC·Filed 2023·Application pending·0 cites
- 1387US12391767B2Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2022·Granted Aug 19, 2025·0 cites·18 claims
- 1487US11384158B2Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2020·Granted Jul 12, 2022·1 cites·26 claims
- 1587US11149093B2Antibodies to symmetrically dimethylated arginine analytes and use thereofARK DIAGNOSTICS INC·Filed 2020·Granted Oct 19, 2021·1 cites·18 claims
- 1687US10690687B2Pregabalin immunoassaysARK DIAGNOSTICS INC·Filed 2018·Granted Jun 23, 2020·2 cites·7 claims
- 1783US11703514B2Pregabalin immunoassaysARK DIAGNOSTICS INC·Filed 2020·Granted Jul 18, 2023·1 cites·11 claims
- 1880US12203938B2Levetiracetam immunoassaysARK DIAGNOSTICS INC·Filed 2021·Granted Jan 21, 2025·0 cites·8 claims
- 1979US2023417779A1Pregabalin ImmunoassaysARK DIAGNOSTICS INC·Filed 2023·Application pending·0 cites
- 2078US2025093340A1Antibodies to methotrexate and uses thereofARK DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 2177US12163955B2Antibodies to methotrexate and uses thereofARK DIAGNOSTICS INC·Filed 2023·Granted Dec 10, 2024·0 cites·9 claims
- 2276US11867705B2Compounds and methods for use in detecting gabapentinARK DIAGNOSTICS INC·Filed 2020·Granted Jan 9, 2024·0 cites·8 claims
- 2374US9970929B2Voriconazole immunoassaysARK DIAGNOSTICS INC·Filed 2014·Granted May 15, 2018·2 cites·16 claims
- 2474US9920136B2Posaconazole immunoassaysARK DIAGNOSTICS INC·Filed 2014·Granted Mar 20, 2018·2 cites·16 claims
- 2574US2019145991A1Compounds and Methods for Use in Detecting GabapentinARK DIAGNOSTICS INC·Filed 2019·Application pending·0 cites
- 2667US2015044693A1Levetiracetam ImmunoassaysARK DIAGNOSTICS INC·Filed 2014·Application pending·0 cites
- 2757US2007218486A1Immunoassays, Haptens, Immunogens and Antibodies for Anti-HIV TherapeuticsARK DIAGNOSTICS INC·Filed 2007·Application pending·0 cites
- 2853US2005244816A1Immunoassays, haptens, immunogens and antibodies for anti-HIV therapeuticsARK DIAGNOSTICS INC·Filed 2004·Application pending·0 cites
- 2952US2009093069A1Topiramate ImmunoassaysARK DIAGNOSTICS INC·Filed 2008·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →